OBJECTIVE: To examine whether a panel of gene polymorphisms, including p53 codon 72 tumor suppressor factor, plasminogen activator inhibitor 1 (PAI-1), and vascular endothelial growth factor (VEGF) -1154, are risk factors for implantation failure after IVF-ET. DESIGN: Case-control study. SETTING: Private laboratories and reproduction medical centers. PATIENT(S): Seventy women with history of recurrent implantation failure after IVF-ET and 73 fertile control women. INTERVENTION(S): Buccal swabs were obtained from all participants. The DNA was extracted from the buccal swabs and analyzed for the presence of the PAI 4G/4G, VEGF -1154A/A, and p53 codon 72 Arg/Pro genotypes. MAIN OUTCOME MEASURE(S): The prevalence of homozygous p53 Pro72, PAI 4G/4G, and VEGF -1154A/A was compared between women experiencing recurrent implantation failure and fertile control women. RESULT(S): The frequencies of homozygous p53 Pro72, PAI 4G/4G, and VEGF -1154AA were significantly higher among women experiencing implantation failure compared with control women. CONCLUSION(S): A panel of tests for p53 codon 72 Pro/Pro, PAI-1 4G/4G and VEGF -1154A/A may be useful to identify women at risk for implantation failure after IVF-ET.
OBJECTIVE: To examine whether a panel of gene polymorphisms, including p53 codon 72 tumor suppressor factor, plasminogen activator inhibitor 1 (PAI-1), and vascular endothelial growth factor (VEGF) -1154, are risk factors for implantation failure after IVF-ET. DESIGN: Case-control study. SETTING: Private laboratories and reproduction medical centers. PATIENT(S): Seventy women with history of recurrent implantation failure after IVF-ET and 73 fertile control women. INTERVENTION(S): Buccal swabs were obtained from all participants. The DNA was extracted from the buccal swabs and analyzed for the presence of the PAI 4G/4G, VEGF -1154A/A, and p53 codon 72 Arg/Pro genotypes. MAIN OUTCOME MEASURE(S): The prevalence of homozygous p53 Pro72, PAI 4G/4G, and VEGF -1154A/A was compared between women experiencing recurrent implantation failure and fertile control women. RESULT(S): The frequencies of homozygous p53 Pro72, PAI 4G/4G, and VEGF -1154AA were significantly higher among women experiencing implantation failure compared with control women. CONCLUSION(S): A panel of tests for p53 codon 72 Pro/Pro, PAI-1 4G/4G and VEGF -1154A/A may be useful to identify women at risk for implantation failure after IVF-ET.
Authors: D D Paskulin; J S L Cunha-Filho; C A B Souza; M C Bortolini; P Hainaut; P Ashton-Prolla Journal: Cell Death Dis Date: 2012-09-27 Impact factor: 8.469
Authors: Radia Boudjenah; Denise Molina-Gomes; Antoine Torre; Florence Boitrelle; Stéphane Taieb; Esther Dos Santos; Robert Wainer; Philippe de Mazancourt; Jacqueline Selva; François Vialard Journal: PLoS One Date: 2014-09-23 Impact factor: 3.240
Authors: Laura D Vagnini; Adriana M Nascimento; Maria do Carmo T Canas; Adriana Renzi; Gabriela R Oliveira-Pelegrin; Claudia G Petersen; Ana L Mauri; João Batista A Oliveira; Ricardo L R Baruffi; Mario Cavagna; José G Franco Journal: Med Princ Pract Date: 2015-08-21 Impact factor: 1.927